1. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Issue 10319 (1st January 2022) Authors: Ramacciotti, Eduardo; Barile Agati, Leandro; Calderaro, Daniela; Aguiar, Valéria Cristina Resende; Spyropoulos, Alex C; de Oliveira, Caroline Candida Carvalho; Lins dos Santos, Jessica; Volpiani, Giuliano Giova; Sobreira, Marcone Lima; Joviliano, Edwaldo Edner; Bohatch Júnior, Milton Sérgio; da F... Journal: Lancet Issue: Volume 399:Issue 10319(2022) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗